For more than a decade, Orange has worked with healthcare partners to provide integrated and patient-centric technology solutions for health professionals, health providers and patients.  In 2007 Orange signalled its commitment to the health sector with the creation of Orange Healthcare.  As an integrated services expert, Orange has the technological know-how and capabilities to develop solutions that are simple, reliable and effective for medical and personal care services. They also contribute to an innovative and enhanced experience for patients when it comes to managing their health and illnesses.

For more information visit: www.healthcare.orange.com or to follow us on Twitter: @OrangeHCare.

Dexcom, Inc., headquartered in San Diego, California, develops and markets continuous glucose monitoring systems for use by diabetes patients, as well as blood glucose monitoring systems used by healthcare providers in hospital critical care settings.   Its newest product, the Dexcom G4 PLATINUM, showcases notable performance enhancements and a host of user conveniences such as vivid color trends, sleek and modern design, and a long wireless transmission distance for greater user mobility.  With the accuracy Dexcom is known for, coupled with desirable and lifestyle-oriented features, users have consistently ranked Dexcom highest in customer satisfaction and loyalty. For more information, visit www.dexcom.com.

Clininfo SA is a French company specializing in the management of clinical studies data. It was created in 1998, originally as technical support to the Clinical Pharmacology Service at University Claude Bernard—Lyon 1 (Professor Boissel), the first in France to conduct large-scale, multi-centre clinical studies.  Our expertise ranges from technical management of large-scale, multi-centre, controlled clinical trials to the development of software applications for the medical field. 

Clininfo's scalable system can be adapted to all research studies, small or large, and put into place quickly to manage data from several dozen to tens of thousands of patients. This adaptability and flexibility are reflected in our products as well as in the proven skills of our team. For more information see www.clininfo.fr.  

Diabetes is limiting the potential of millions of people across the Middle East, Africa and Asia, including an increasing number of younger people. 

The Etisalat Group, for the second time, is participating in the tour with an official team of employees from across 19 countries the telecommunications company operates in.  Applicants are being evaluated in their respective counties using a variety of sophisticated health, fitness and psychological criteria using the expertise of local teams and the Etisalat Group. 

Etisalat’s staff are standing up and showing that they too want to contribute to the global fight against diabetes. Not only are they raising awareness in their communities and pursuing more active lifestyles themselves, they are making a tangible contribution to developing real solutions to the disease.

Thanks to its dual activity provider in insulin pump therapy and provision of medical devices dedicated to diabetes, Dinno Santé  allows us to offer a real expertise in the comprehensive care of diabetic patients.

Indeed it offers to patients: a benefit for quality insulin pump, blood glucose meters and continuous glucose monitoring system Dexcom to facilitate their daily lives.

Because every patient is unique, Dinno Santé  works closely with medical teams to adapt flexibly and availability, and offer a true service "tailored" sometimes exceeding initial obligations.

www.dinnosante.fr

ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON’s innovation focuses on the factors that are critical to our clients – reducing time, reducing cost and increasing quality in clinical development. See: www.iconplc.com 

IDF Europe is the European chapter of the International Diabetes Federation (IDF). We are umbrella organization representing 70 diabetes organizations in 47 countries across Europe.  We are a diverse and inclusive multicultural network of national diabetes associations, representing both people living with diabetes and healthcare professionals.

Through our activities, we aim to influence policy, increase public awareness and encourage health improvement, promote the exchange of best practice and high-quality information about diabetes throughout the European region.

We provide essential expertise and up-to-date evidence on diabetes, support awareness campaigns through a network of partners and stakeholders, and advocate European and international organizations for proper public policies for diabetes. www.idf-europe.org

JDRF is the type 1 diabetes charity, improving lives until we find the cure. We’re totally focused on type 1 diabetes, and are run by people with type 1, for people with type 1.

JDRF fund research to cure, treat and prevent type 1 diabetes. We provide information for children, adults and parents living with the condition, at all stages from diagnosis and beyond. We give a voice to people with type 1 diabetes and campaign for increased focus on, and funding for, research to find the cure.

JDRF is a global organisation working towards the cure. Internationally, we are the world’s leading charitable funder of type 1 diabetes research investing £1billion in funding critical research to cure, treat and prevent type 1 diabetes and its complications.

The Geneva Diabetics Association (AGD) has the goals of defending the interests of people with diabetes in all domains, providing them and their close ones, the best information possible, promoting detection and prevention of diabetes, encouraging research in scientific and social fields, selling products for control of blood glucose levels and material for injection.

The AGD encourages physical activity as part of the overall management of diabetic patients. In this respect, it emphasizes the importance of regular and appropriate physical activity, having a beneficial effect on cardiovascular risk and overall well-being.

Founded in 1954, the AGD is a non-profit association of persons with or concerned by diabetes, and has approximately 1100 members. It is a member of the Swiss Diabetes Association.

The Personal Connected Health Alliance (PCHA), a global, non-profit organization, is a collaboration between Continua, mHealth Summit and HIMSS, focused on engaging consumers with their health via interoperable personalized health solutions that meet their lifestyle needs. PCHA is an independent HIMSS organization, combining the dynamic membership and expertise of Continua, and the networking and reach of the mHealth Summit and global mhealth events, with the global access and leadership of HIMSS to bring greater focus on personal connected health technology. Representing the consumer voice in personal connected health, PCHA brings together a unique combination of domestic and global resources focused on personalized health solutions that meet the needs of consumers throughout their lives. Visit www.PCHAlliance.org. 

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 35 years, the Accu-Chek brand has been dedicated to enable people with diabetes to live life as normal and active as possible as well as to empower healthcare professionals manage their patients’ condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management. It encompasses blood glucose meters, insulin delivery systems, lancing devices, data management systems and education programs – contributing to an improved medical outcome. For more information: www.accu-chek.com.

We Are Patients is a media presenting endearing personalities with chronic diseases, and their families. The media follows those people: their stories, their lives, their mobilizations. For now, We Are patients talks about two pathologies: lymphoma and diabetes. http://wearepatients.com/

Glycosmedia was established in 2008 and is a free, non-promotional, editorially independent news service about developments in diabetes. Our free newsletter has a global audience and is primarily aimed at health professionals. It is sent out every week by email free of charge to our subscribers. The contributing editors are consultant diabetologists and write regular monthly updates and a journal watch feature that can be seen on the website.

Glycosmedia has also developed a free App for iPhone and iPad which can be downloaded from the iTunes store.

Glycosmedia is grateful to all our sponsors for enabling the production of our news service. 

http://www.glycosmedia.com/.

Lancé en avril 2015 par le Groupe aufeminin, Onmeda figure parmi les principaux sites dédiés à la santé et au bien-être en France. Avec 10 000 pages de contenus (validés par une équipe d’experts et de médecins), 20 000 pages médicaments et plus 300 vidéos en ligne, Onmeda se positionne comme le relais de l’innovation santé, optimisant l'utilisation des nouvelles technologies.

Onmeda est aujourd'hui l’un des leaders de l’information santé pour le grand public, en Europe. Premier site de santé en Allemagne, avec plus de 10 millions de visiteurs uniques par mois[1], Onmeda est également présent en Espagne depuis 2012, où le site compte 3,5 millions de visiteurs uniques par mois^[1].   http://www.onmeda.fr/